Soy, isoflavone consumption not associated with endometrial cancer risk
the ONA take:
According to a new study published in the journal BJOG, an international journal obstetrics and gynecology, researchers from the National Cancer Center in Tokyo, Japan, have found that soy food/isoflavone consumption is not associated with endometrial cancer risk in Japanese women.
For the study, researchers sought to investigate whether a correlation exists between soy food/isoflavone consumption and endometrial cancer risk because consumption of soy food in Japan is very high while endometrial cancer incidence is very low.
Researchers conducted a prospective cohort study that included 49,121 Japanese women aged 45 to 74 years. Participants completed self-administered food frequency questionnaires that assessed intake of soy foods and isoflavones between 1995 and 1998, followed by a 5-year follow-up survey.
Results showed that during an average follow-up of 12.1 years, there were 112 cases of newly diagnosed endometrial cancer. The researchers found no association between soy food and isoflavone consumption and endometrial cancer risk.
Soy food/isoflavone consumption is not associated with endometrial cancer risk in Japanese women.
- Novel Colonoscopy Prep Is Poised to Improve Screening Rates for Colon Cancer
- Short-Term Intervention May Have Long-term Diet Effect in Hispanic Breast Cancer Survivors
- How Physical Changes From Breast Cancer Affect Self-Image: Considerations for Clinicians
- Childhood Cancer Linked to Poor Diet Quality in Adult Survivors
- Low-Dose Sublingual Fentanyl Safe, Effective in Patients Receiving Lower Opioid Doses
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Sugar and Cancer: Mitigating the Affects of Diet on Cancer
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Implementing a Distress Screening Process for Cancer Patients
- Initiating Palliative Care in the Emergency Department
- Study Suggests More Men With Prostate Cancer Would Choose Active Surveillance if it Were Offered
- The Bounty of Failure: A Well-Versed Nursing Experience
- Olaratumab in Combo With Doxorubicin Approved for Soft Tissue Sarcoma
- POLST Programs Can Benefit from the Relationship Between Patients and Nurse Practitioners
- Hydroxyurea May Improve Kidney Function in PV-Associated Nephrotic Syndrome
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|